174 related articles for article (PubMed ID: 34559977)
1. Laryngeal myasthenia gravis following influenza vaccination: a case report and literature review.
Wang F; Xiang T; He L; Wang J
Hum Vaccin Immunother; 2021 Dec; 17(12):5529-5531. PubMed ID: 34559977
[TBL] [Abstract][Full Text] [Related]
2. A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis.
Strijbos E; Tannemaat MR; Alleman I; de Meel RHP; Bakker JA; van Beek R; Kroon FP; Rimmelzwaan GF; Verschuuren JJGM
Vaccine; 2019 Feb; 37(7):919-925. PubMed ID: 30660402
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis following human papillomavirus vaccination: a case report.
Chung JY; Lee SJ; Shin BS; Kang HG
BMC Neurol; 2018 Dec; 18(1):222. PubMed ID: 30593270
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial).
Tackenberg B; Schneider M; Blaes F; Eienbröker C; Schade-Brittinger C; Wellek A; Deschauer M; Eickmann M; Klenk HD; Müller HH; Sommer N
EBioMedicine; 2018 Feb; 28():143-150. PubMed ID: 29337134
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of laryngeal myasthenia gravis: A case series.
Yang X; Niu L; Yang C; Wang L; Liu J; He G
Am J Otolaryngol; 2019; 40(2):292-296. PubMed ID: 30497698
[TBL] [Abstract][Full Text] [Related]
6. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature.
Virgilio E; Tondo G; Montabone C; Comi C
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612789
[TBL] [Abstract][Full Text] [Related]
8. Isolated dysarthria as the sole manifestation of myasthenia gravis: a case report.
Li W; He L; Jin X; Li L; Sun C; Wang C
J Int Med Res; 2022 Jul; 50(8):3000605221109395. PubMed ID: 35915860
[TBL] [Abstract][Full Text] [Related]
9. MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review.
Santilli A; Stitt D
Neurologist; 2021 Sep; 26(5):175-177. PubMed ID: 34491934
[TBL] [Abstract][Full Text] [Related]
10. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
11. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
Fanella G; Baiata C; Candeloro E; Toscano G; Colnaghi S; Mauri M; Cariddi LP; Rebecchi V; Solazzo F; Banfi P; Piatti M; Ferrarese C; Versino M
Neurol Sci; 2022 Oct; 43(10):5799-5802. PubMed ID: 35870026
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
Vincent A; Leite MI
Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
[TBL] [Abstract][Full Text] [Related]
13. Spontaneously resolving late-onset ocular myasthenia related to COVID-19. A case report.
Popescu C
Acta Myol; 2023; 42(2-3):89-91. PubMed ID: 38090545
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
15. [Myasthenia gravis].
Schodrowski J; Seipelt M; Adibi-Sedeh I; Eienbröker C; Tackenberg B
Internist (Berl); 2016 Apr; 57(4):349-61. PubMed ID: 27000188
[TBL] [Abstract][Full Text] [Related]
16. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
17. Successful Transition from Plasma Exchange to Eculizumab in Acetylcholine Receptor Antibody- and Muscle-Specific Kinase (MuSK) Antibody-Negative Myasthenia Gravis: A Case Report.
Greenwood GT; Lynch Z
Am J Case Rep; 2020 May; 21():e921431. PubMed ID: 32417849
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis in a young Papuan woman.
Trevett AJ; Nwokolo N
P N G Med J; 1993 Sep; 36(3):243-5. PubMed ID: 8059551
[TBL] [Abstract][Full Text] [Related]
19. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
[TBL] [Abstract][Full Text] [Related]
20. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
Auriel E; Regev K; Dori A; Karni A
Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
